Role of novel terpenes in transcutaneous permeation of valsartan: Effectiveness and mechanism of action

Drug Development and Industrial Pharmacy

Volumn 37, Issue 5, 2011, Pages 583-596

  Ahad, Abdul ^a   Aqil, Mohammed ^a   Kohli, Kanchan ^a   Sultana, Yasmin ^a   Mujeeb, Mohd ^a   Ali, Asgar ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

hypertension; permeation enhancer; terpenes; Transdermal; valsartan

Indexed keywords

BETA CITRONELLENE; CINEOLE; ISO EUCALYPTOL; LAVANDULOL ACETATE; PRENOL; ROSE OXIDE; SAFRANAL; TERPENE; UNCLASSIFIED DRUG; VALENCENE; VALSARTAN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CADAVER; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG PENETRATION; DRUG STRUCTURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFRARED SPECTROSCOPY; LIPID BILAYER; NONHUMAN; RAT; SKIN IRRITATION; SKIN PERMEABILITY; THERMOGRAPHY;

ADMINISTRATION, CUTANEOUS; ANIMALS; CADAVER; DRUG DELIVERY SYSTEMS; HUMANS; PERMEABILITY; RATS; RATS, WISTAR; SKIN; SKIN ABSORPTION; TERPENES; TETRAZOLES; VALINE;

EID: 79953771561     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.532219     Document Type: Article

References (47)

1. Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M et al. (2009).Chemical penetration enhancers: a patent review. Expert Opin Ther Pat, 19:969-988.
2. Amin S, Kohli K, Khar RK, Mir SR, Pillai KK. (2008).Mechanism of in vitro percutaneous absorption enhancement of carvedilol by penetration enhancers. Pharm Dev Technol, 13:533-539.
3. Amnuaikita C, Ikeuchia I, Ogawaraa K, Higakia K, Kimura T. (2005). Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use. Int J Pharm, 289,167-178. (Pubitemid 40093551)
4. Aqil M, Ahad A, Sultana Y, Ali A. (2007). Status of terpenes as skin penetration enhancers. Drug Dis Today, 2007, 12, 1601-1607.
5. Aqil M, Ali A, Sultana Y, Parvez N. (2004). Matrix type transdermal drug delivery systems of metoprolol tartrate: skin toxicity and in vivo characterization. Eth Pharm J, 22, 55-50.
6. Bhatia KS, Gao S, Freeman TP, Singh J. (1997).Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J Pharm Sci, 86:1011-1015. (Pubitemid 27382902)
7. Chisty MN, Bellantone RA, Taft DR, Plakogiannis FM. (2002).In vitro evaluation of the release of albuterol sulfate from polymer gels: effect of fatty acids on drug transport across biological membranes. Drug Dev Ind Pharm, 28:1221-1229. (Pubitemid 35416651)
8. Cornwell PA and Barry BW. (1991). The effects of a series of homologous terpene alcohols on the lipid structure of human stratum corneum as assessed by differential scanning calorimetry. In Scott RC, Guy RH, Hadgraft J and Boddr HE. (Eds), Prediction of Percutaneous Penetration, IBC Technical Services, London, Vol. 2, 394-400.
9. Cornwell PA, Barry BW, Bouwstra JA, and Gooris GS. (1996). Modes of action of terpene penetration enhancers in human skin; differential scanning calorimetry, smallangle X-ray diffraction and enhancer uptake studies. Int J Pharm, 127, 9-26. (Pubitemid 26069150)
10. Cornwell PA, Barry BW. (1994).Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J Pharm Pharmacol, 46:261-269. (Pubitemid 24111129)
11. El-Kattan AF, Asbill CS, Kim N, Michniak BB. (2001).The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicities. Int J Pharm, 215:229-240. (Pubitemid 32206620)
12. Fang C, Liu Y, Ye X, Rong ZX, Feng XM, Jiang CB et al. (2008).Synergistically enhanced transdermal permeation and topical analgesia of tetracaine gel containing menthol and ethanol in experimental and clinical studies. Eur J Pharm Biopharm, 68:735-740. (Pubitemid 351318188)
13. Fujii M, Takeda Y, Yoshida M, Matsumoto M, Watanabe Y. (2004).Enhancement effect of p-menthane-3,8-diol on in vitro permeation of antipyrine and indomethacin through Yucatan micropig skin. Drug Dev Ind Pharm, 30:673-677. (Pubitemid 38924637)
14. Godwin DA, Michniak BB. (1999).Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev Ind Pharm, 25:905-915. (Pubitemid 29350272)
15. Goodman M, Barry BW. (1989). Action of penetration enhancers on human stratum corneum as assessed by differential scanning calorimetry. In: Bronaugh RL, Maibach HI. (eds) Percutaneous absorption. Marcel Dekker, New York and Basel. 567-593.
16. Higaki K, Amnuaikit C, Kimura T. (2003). Strategies for overcoming the stratum corneum: chemical and physical approaches. Am J Drug Deliv, 1, 187-214.
17. Hori M, Satoh S, Maibach HI, Guy RH. (1991).Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro: effect of enhancer lipophilicity. J Pharm Sci, 80:32-35.
18. Jain AK, Thomas NS, Panchagnula R. (2002).Transdermal drug delivery of imipramine hydrochloride. I. Effect of terpenes. J Control Release, 79:93-101. (Pubitemid 34168193)
19. Jain R, Aqil M, Ahad A, Ali A, Khar RK. (2008).Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride. Drug Dev Ind Pharm, 34:384-389. (Pubitemid 351519668)
20. Kanikkannan N, Singh M. (2002).Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. Int J Pharm, 248:219-228. (Pubitemid 35341424)
21. Karakatsani M, Dedhiya M, Plakogiannis FM. (2010).The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl. Drug Dev Ind Pharm, 36:1195-1206.
22. Kararli T, Kirchhoff CF, Penzotti Jr SC. (1995). Enhancement of transdermal transport of azidothymidine (AZT) with novel terpene and terpene like enhancers: in vivo-in vitro correlations. J Control Rel, 34, 43-51.
23. Krishnaiah YS, Al-Saidan SM, Chandrasekhar DV, Satyanarayana V. (2005).Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers. J Control Release, 106:111-122. (Pubitemid 41140086)
24. Krishnaiah YS, Satyanarayana V, Bhaskar P. (2002a).Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int J Pharm, 247:91-102. (Pubitemid 35341141)
25. Krishnaiah YS, Satyanarayana V, Bhaskar P. (2003).Enhanced percutaneous permeability of nicardipine hydrochloride by carvone across the rat abdominal skin. Drug Dev Ind Pharm, 29:191-202. (Pubitemid 36292942)
26. Krishnaiah YS, Satyanarayana V, Karthikeyan RS. (2002b).Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J Pharm Pharm Sci, 5:123-130.
27. Kunta JR, Goskonda VR, Brotherton HO, Khan MA, Reddy IK. (1997).Effect of menthol and related terpenes on the percutaneous absorption of propranolol across excised hairless mouse skin. J Pharm Sci, 86:1369-1373. (Pubitemid 28018316)
28. Moghimi HR, Makhmalzadeh BS, Manafi A. (2009).Enhancement effect of terpenes on silver sulphadiazine permeation through third-degree burn eschar. Burns, 35:1165-1170.
29. Mura S, Manconi M, Sinico C, Valenti D, Fadda AM. (2009).Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. Int J Pharm, 380:72-79.
30. Narishetty ST, Panchagnula R. (2004a).Transdermal delivery of zidovudine: effect of terpenes and their mechanism of action. J Control Release, 95:367-379. (Pubitemid 38340488)
31. Narishetty ST, Panchagnula R. (2004b).Transdermal delivery system for zidovudine: in vitro, ex vivo and in vivo evaluation. Biopharm Drug Dispos, 25:9-20. (Pubitemid 38159259)
32. Ogiso T, Iwaki M, Paku T. (1995).Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci, 84:482-488.
33. Panchagnula R, Salve PS, Thomas NS, Jain AK, Ramarao P. (2001).Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin. Int J Pharm, 219:95-105. (Pubitemid 32391369)
34. Paudel KS, Hammell DC, Agu RU, Valiveti S, Stinchcomb AL. (2010).Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers. Drug Dev Ind Pharm, 36:1088-1097.
35. Rizwan M, Aqil M, Ahad A, Sultana Y, Ali MM. (2008).Transdermal delivery of valsartan: I. Effect of various terpenes. Drug Dev Ind Pharm, 34:618-626. (Pubitemid 351878682)
36. Sapra B, Jain S, Tiwary AK. (2008).Percutaneous permeation enhancement by terpenes: mechanistic view. Aaps J, 10:120-132.
37. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2008).Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotechnology, 6:8.
38. Shams MS, Alam MI, Ali A, Sultana Y, Aqil M. (2010).Pharmacodynamics of a losartan transdermal system for the treatment of hypertension. Drug Dev Ind Pharm, 36:385-392.
39. Silva CL, Nunes SC, Eusébio ME, Sousa JJ, Pais AA. (2006).Study of human stratum corneum and extracted lipids by thermomicroscopy and DSC. Chem Phys Lipids, 140:36-47.
40. Sinha VR, Kaur MP. (2000).Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm, 26:1131-1140.
41. Tatar S, Saglä-k S. (2002).Comparison of UV- and second derivativespectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation. J Pharm Biomed Anal, 30:371-375. (Pubitemid 35013504)
42. Vaddi HK, Ho PC, Chan SY. (2002).Terpenes in propylene glycol as skinpenetration enhancers: permeation and partition of haloperidol, Fourier transform infrared spectroscopy, and differential scanning calorimetry. J Pharm Sci, 91:1639-1651. (Pubitemid 34680226)
43. Williams AC and Barry BW. (1989). Permeation, FTIR and DSC investigations of terpene penetration enhancers in human skin. J Pharm Pharmacol, 41, 12P. (Pubitemid 20102719)
44. Williams AC and Barry BW. (1991). The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm, 74, 157-168.
45. Williams AC, Barry BW. (2004).Penetration enhancers. Adv Drug Deliv Rev, 56:603-618. (Pubitemid 38326936)
46. Yamane MA, Williams AC, Barry BW. (1995).Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol, 47:978-989. (Pubitemid 26048166)
47. Yum S, Lee E, Taskovich L, Theeuwes F. (1994). Permeation Enhancement with Ethanol: Mechanism of Action through Skin. In Drug Permeation Enhancement; Hsich, D.S., Ed.; Marcel Dekker: New York, 143-170.